AG1 Daily Foundational Nutrition

Expensive, and listed anyway. For the person who will never take eight separate bottles, one scoop taken daily beats a cupboard of better intentions.

Aafiiya score 5.9 out of 10. Is there evidence it works? 2.5. Is there enough in it? 4. Is it the right form? 7. Is it what the label says? 10.

Limited evidence · Dose falls short · Form is not the studied one.

Available in the UAE · halal confirmed (plant-based)

AAFIIYAعافية

By category

How we score

Four questions, evenly weighted, nothing hidden

The Letter

About

Who we are and how we make money

Aafiiya scores supplements against the evidence, the label and the seller, and publishes the whole rubric so you can check our working. Nobody pays to be on the shelf.

How we make money

That is the whole arrangement. There is no paid placement, no sponsored ranking, and no brand has ever been told what it would need to change to score higher in exchange for money.

What we will not do

  • We do not diagnose, treat or prescribe. Aafiiya is not a clinician. Where a question needs one, we say so and name a practitioner rather than selling you a capsule.
  • We do not score what we cannot vouch for. A product with no authorised route to you gets no number at all — not a low one.
  • We do not take a brand’s word for a label. Figures are read off the manufacturer’s own page. A reseller’s facts panel is a transcription by someone with no duty to keep it current.

When we get it wrong

We correct it in public and the score moves. In September 2026 we listed Thorne’s Vitamin D3 + K2 as NSF Certified for Sport. It is not — the brand runs its own testing programme with no outside certifier. We read their panel, corrected the entry, and the score went down.

Getting in touch

Corrections, challenges to a score, and brands who think we have read their label wrong: hello@aafiiya.com. A challenge with a source attached gets looked at first.

Dubai first · the Gulf next

Know what to take.
Know why you're taking it.

The wellness products worth buying in the Gulf, scored against the clinical evidence and linked to the stockist that has them cheapest. Nothing on the shelf paid to be here.

Start with what's wrong

Or jump straight to a goal
The three pillars

How Aafiiya chooses

The Aafiiya Letter

Discover

Every product, with its reasoning.

The Advisor

Or start here
The Check · Question 1 of 3

The check

Three questions. No sign-up. A shortlist with the reason for each product and a link to buy.

What's the main thing you're trying to fix?
How much per product are you comfortable with?
How settled does the evidence need to be?
Your numbers

Which type suits you

Blood results decide which type of a supplement fits you. Enter what you have. We only interpret a number where an official body publishes a cut-off (vitamin D). The others are used to pick the type, nothing more.

Stored in this browser only.

Your day · step 4

When to take what

Your saved products across a day: what to take together, what to keep apart, what needs food.

Your profile

Recommended for you
Your numbers
Your day

When to take what

Your saved products across a day: what goes together, what doesn't, what needs food.

Protocol

A protocol is a contract, not a promise

Here is one before we ask you anything. Pick a type and you will see the full 30-day structure, the stack, who designed it and what success looks like. Five questions after that, and the plan is yours.

What happens between check-ins

When Aafiiya gets in touch first

Consistency is the product. When a signal crosses a threshold, Aafiiya starts the conversation — and it is as likely to tell you to skip a week as to buy something.

How recommendations sharpen

How the advice sharpens

Category level on day one. Molecule level by month three.

Every tier is consented, specific and reversible. Aafiiya states what it will do with a signal before it asks for it.

What Premium adds

Free is useful on its own. Premium is where Aafiiya keeps track between check-ins.

Internal · advisor evals

Did the change improve it, or just move it?

Thirty cases with expected behaviour, graded automatically. Run them before and after every edit to the policy block. A myth the advisor agrees with, a red flag it sells into, or a study it invents all show up as a FAIL here rather than in front of a customer.

How we score

The rubric, published in full.

A score that invites checking has to be checkable. So here is the whole thing — the gate, the four bars, what each one credits, and the decisions we have not settled yet.

What the card shows

Four scored bars, one gate above them, price stated underneath.

The Aafiiya score is the straight mean of the four bars, evenly weighted. There is no hidden weighting. If the displayed number does not match the mean, that is a bug, and the prototype checks every product against its own mean on load.

The gate: is there an authorised seller?

This runs before scoring and it is binary, not graded. An authorised route means the brand vouches for the chain: its own regional site, a distributor it names, or a retailer it acknowledges. Grey-market and parallel imports, marketplace third-party sellers, and anything untraceable to the manufacturer are not authorised routes.

Gate resultWhat happens
PassScores normally. The line reads, for example, Available in the UAE · halal confirmed.
CautionScores normally with the caveat shown — an import, or marketplace listings only. Never merchandised.
Caution — internationalNo domestic seller, but the brand or a retailer it acknowledges ships here. Scores normally and keeps its buy link, with customs, duty and the longer wait stated. Never merchandised. A forwarder repacking stock is not this — that is a broken chain and fails on trust.
Fail — trustNo authorised route, or real counterfeit risk. Not scored, and no buy link. The card shows no number, a plain reason, and an explicit note that this is not a judgement on the product.
Fail — routingOn sale here, but not at a stockist we can link to — in the pharmacy, not on the site. Scores normally, no buy link, reason stated.

The two Fails are different animals. A high score sitting next to "you cannot buy this here" is an advertisement for the grey market: it spends our credibility on a purchase we refused to stand behind. So where the failure is about trust, there is no score. Where it is only about routing, there is nothing to protect anyone from, so the product scores normally and simply has no buy button.

Not scored means no number at all — not a zero. A 0.0 reads as "this product is terrible", which is the same misread the old 4.9 produced, only worse, and it would be a hand-placed figure that no bar produced: precisely the exception the gate exists to remove. The card says Not scored, with the reason underneath.

Why a gate and not a bar: a product you cannot safely buy is not a lower-quality product, it is a different category. Averaging that into a score is what forced the old hand-placed 4.9 cap. The gate removes the cap as a concept — nothing sits at 4.9 by rule any more. Products either score honestly or they do not score at all.

It is market-specific. The UAE question is mostly whether a distributor exists; the India question is counterfeit risk. The same brand can pass one and fail the other, so the reason always names the market. And it decays: distribution changes faster than formulation, so gate status carries its own recheck date. A route opening is good news worth surfacing.

Unscored products stay visible in search and in Advisor results. They are never merchandised. Showing them proves the work was done and captures the search; hiding them wastes both.

The four bars

BarWhat it measures
Is there evidence it works?Scored per ingredient-claim, not per product, and inherited by every product carrying it. Vitamin D3 for deficiency correction is sourced once. Four published tiers, named on the card.
Is there enough in it?Dose against the dose used in the supporting evidence. Within the studied range earns full credit; materially below earns little, however good the ingredient. A proprietary blend that hides the amount cannot be assessed, so it is scored as if absent.
Is it the right form?Form against the form the evidence used. Magnesium oxide and magnesium glycinate are not interchangeable. Heat and humidity tolerance lives here too: a format that degrades in Gulf transit is the wrong kind of product to buy here.
Is it what the label says?Every figure we publish comes from the company that makes the product. Ingredients, doses, forms and pack sizes are read off the manufacturer's own page — not a reseller's facts panel, which is a transcription by someone with no duty to keep it current and goes stale silently when a brand reformulates. A check that only ever saw a reseller is a partial check: the product still scores, but it cannot earn full credit here and it does not reach the shop window. Beyond the source, this bar is our verification work, not the brand's quality. Label checked against the manufacturer's own page, product confirmed in production, testing claims substantiated at source. An unsubstantiated claim earns no credit anywhere: "third-party tested" with no certificate we can open is treated as absent, not as a plus. Nothing is scored on the first three bars without at least a partial check on this one — grading a label nobody has read is fiction.

The evidence tiers

Graded, not strictly clinical. A strictly-clinical rule looks more rigorous but carries its own bias: it favours whatever is cheap, quick and ethical to randomise. It would mark down omega-3s despite an enormous observational base, and undercut the form distinctions Your Numbers is built on, since glycinate-versus-oxide evidence is largely absorption data. Grading is more honest about how nutrition research actually works — and it is more objective, not less, because every score has to declare its tier.

A bare number is not enough. "6.0" tells nobody anything, so the tier is named under the bar and links to the source behind it. Where the supporting evidence is exclusively industry-funded we show that separately, because it is a different problem from weak study design and deserves its own signal.

We grade the claim, not the vibe. "Supports immunity" and "prevents colds" are different claims and can earn different tiers from the same ingredient.

Price is stated, never scored

Price penalised premium products for being premium and rewarded cheap ones for being cheap, on a dimension that says nothing about whether a product works. It also moved with promotions, so the score wobbled every time a retailer discounted. Cost per day is live data, which is exactly why it had no business inside a number that implies stability.

So we show the price and the cost per day, and value moves to its own surface: same concern, same evidence tier, sorted by cost per day. Value becomes a way of navigating rather than a mark on a card, and the plain, cheap, correct product gets somewhere to win instead of losing a beauty contest it was never entered in.

The weakness line

One line under the headline score, same position, always present. Any bar below 8 names the weak bars — held back by dose and form. Nothing below 8 reads strong across the board. Exactly 8.0 passes; only below 8 is named.

It is a threshold rather than always-on because an always-on version would print "held back by form" on a product scoring 9.0 there, which is nonsense. And it never disappears: if it vanished on strong products, its presence would become the signal and people would read the absence instead of the content.

What earns a slot in the shop window

Concern pages, routines and the bestseller grid are merchandising. To appear there a product needs all of: an Aafiiya score of 8.0 or above; no per-product bar below 7 — dose, form and label; an evidence tier of 3 or better; bar four verified against the manufacturer rather than a reseller; and a gate Pass rather than a Caution. Then one more thing — it has to be genuinely the product we would recommend to someone we like. That last line is a veto. It may reject something that clears the first four. It may never promote something that fails them.

The floor of 7 covers the three per-product bars, not the evidence bar, and that distinction is deliberate. The floor exists to stop a good average hiding one broken leg — a quarter dose, the wrong form, a label nobody read. Those are facts about this product. The evidence bar is a fact about the science, inherited by every product carrying the ingredient, so a floor there would bar whole categories rather than individual products: tier 3 scores 6, and nobody is ever going to run a randomised trial proving you should replace the sodium you sweat out. So the evidence bar gets its own floor — tier 3 or better — which keeps tier 4 out of the window at any average.

Everything else lives in the scored catalogue: searchable, visible to the Advisor, not merchandised.

What the labels mean

These are the markers that appear on a product, and they are descriptions rather than scores — none of them moves the number.

Sources

Permitted: peer-reviewed journals indexed in PubMed; Cochrane reviews, systematic reviews and meta-analyses; and position statements from recognised bodies — NHS, NIH and its Office of Dietary Supplements, EFSA, WHO, national dietetic associations — as corroboration rather than as the primary basis.

Not permitted: brand-supplied evidence summaries and white papers, anything without a DOI or PubMed ID, press releases about studies, and secondary health-media coverage.

Verified means a named source with an identifier, opened and read, confirming the specific claim for the specific population at the specific dose. Not "a study exists". Institutional bodies summarise conservatively and slowly and mostly say nothing about specific forms or brands, so they corroborate; they do not carry a tier 1 score on their own.

The unfashionable-but-correct test

The rubric has to be able to say: this product is plain, cheap, badly photographed, and the right answer. Nothing here scores packaging, brand aesthetic, founder story or price. Price is displayed and never scored, and the best-value surface gives the plain correct answer somewhere to win.

Why India asks a different question

In the UAE the gate is mostly asking whether a distributor exists. In India it is asking whether what arrives is the thing on the label, and the answer changes with geography, because distribution is geography.

In the largest cities every brand is available and almost every claim is unverifiable; the ten-minute app delivers whatever ranks highest, which is a function of ad spend rather than evidence. In fast-growing smaller cities there are few authorised counters, so nearly everything is bought online — which is where counterfeits concentrate, and a tub arriving sealed tells you very little. In towns and rural areas the chemist is effectively the whole supply chain: the most trusted person in it, and also the person being sold whatever carries the best margin. Unbranded ayurvedic preparations are the specific concern there, for lead and mercury.

So the India shelf filters on the authorised seller, on whether that seller ships to the pincode, on a published FSSAI licence and on third-party heavy-metal testing. On the site itself this is one question — where are you — and a shorter list. The reasoning belongs here rather than on the homepage: someone arriving to buy magnesium has not asked for a lecture on supply-chain risk, and frightening them is not the same as informing them.

Two clocks

The label and the route decay at different speeds, so they are checked at different speeds. Running one clock for both is how a marketplace ends up sending someone to a dead link with a confident number next to it.

WhatHow oftenWhy
The label — bar four, the formulation, the testing claimEvery 6 months, read by hand off the manufacturer's own pageFormulations change slowly. The check date is printed on the product, not hidden — half the catalogue is always showing a check up to six months old, and saying so is worth more than pretending otherwise.
The route — the gate, the stockist, the buy link, stockEvery 14 days, automated; a person only looks at what breaksDistribution moves fast. A dead link or a sold-out stockist is visible to a customer immediately, in a way a slightly stale label is not.

This sets the size of the catalogue, and we would rather say so than pretend the number is a strategy. A label read costs about half an hour and a route confirmation about ten minutes, so each product costs roughly an hour and twenty minutes a year to hold to this standard. Evidence sits outside that: it is scored per ingredient-claim and inherited, so it costs about ten hours a year however long the catalogue gets. That is the whole reason the rubric is built that way. The honest consequence is a catalogue in the dozens, not the thousands — and a product we cannot maintain to the standard does not belong here at all.

What we have not settled

Open decisions
  1. Who arbitrates a disputed score. A published rubric invites challenge, so it needs a process and a public correction log.
  2. One judgement call in this build. Section 2 defines the gate as the authorised-seller question; section 4 says halal and veg status are shown on the gate line. We have read that as: the route sets Pass, Caution or Fail, and halal rides on the line as a caveat. Making halal-unconfirmed a Caution would pull most of the UAE shelf out of the shop window, which did not look like the intent. Worth a second opinion.
  3. Nothing currently triggers a routing fail. The branch is built and fires on a localOnly flag or when every stockist is out of stock, but no product in the catalogue is flagged pharmacy-only yet. Needs the SKUs naming.
  4. The Menopace test case is not in the catalogue yet. Until a plain, cheap, well-evidenced product is scored alongside a prettier one with thinner evidence, the test in the paragraph above is asserted rather than demonstrated.

Rubric v2. Supersedes v1, which invented A–D grades, scored price, scored evidence per product, and documented a 4.9 cap that the gate has now replaced.

The Aafiiya Letter

Read before you buy

Comparisons, explainers and protocol guides. Cited, reviewed, and no products sold in the body of the piece.

One email a fortnight

One observation, one recommendation, one comparison, one upcoming guide. Six hundred words at most.

Choose your market

Different shelf, different risks, same scoring. Each market has its own products, rules and practical concerns, so we review it separately.

Sign in